Dacryocystitis Market
Global Dacryocystitis Market Size, Share & Trends Analysis Report By Product (Oral Antibiotics, Systemic Antibiotics, Surgery, and Others) By Application (Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, and Others) By End-User (Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, and Others) Forecast 2021-2027
The global Dacryocystitis market is anticipated to grow at a CAGR during the forecast period (2021-2027). Dacryocystitis is an infection or inflammation of the nasolacrimal sac, usually escorted by obstruction of the nasolacrimal duct. Dacryocystitis can be acute or chronic and congenital or acquired. It is more common in females. It tends to occur either in infants (uncommon) or in adults (much more common) over the age of 40 years, peak age 60-70 years. The global Dacryocystitis market is driven by the rising prevalence of eye infections among the population globally. Due to this, the demand for effective treatment to cure Dacryocystitis is surging, thereby, leading to market growth. As per the National Institute of Health, in 2017, around 6-30% of the general population and up to 30% of the children across the globe were affected with conjunctivitis. Besides, 1 in 300 people suffer from an eye infection including Dacryocystitis each year. In addition, as per the CDC, every year, Americans make nearly a million doctor visits for eye infections, resulting in $175 million in direct health care costs. Owing to the high prevalence rate and healthcare expenditure, the market is showing impressive growth.
Moreover, rapid technological advancements in the field of ophthalmology and increasing surgical procedures associated with eye infections are the other factors that are further projected to accelerate the market growth. However, lack of awareness among patients about the infection may hamper the market growth, whereas new product launches by the key players operating in the market and emerging markets in major economies can bring lucrative growth opportunities in the Dacryocystitis market during the forecast period.
Impact of COVID-19 on Global Dacryocystitis Market
The Dacryocystitis market has registered a decline in growth due to the COVID-19 pandemic. The sudden outbreak globally limited the market growth. Due to government restrictions on mobility, the number of patient visits in the hospitals and clinics was reduced. Patients affected with eye infections were more prone to be at high risk of being infected. As per the US National Library of Medicine National Institutes of Health, nearly 87% of the eye surgeons agreed that lacrimal procedures were associated with a high risk of COVID-19 transmission. Due to this, most of the lacrimal procedures have to be put on hold, resulting in less treatment demand. Moreover, the delay or cancellation of non-urgent and lacrimal procedures led to a decreased patient pool. Apart from these, the mobility restriction affected the supply chain that resulted in the delay in product supply to end-users.
Segmental Outlook
The global Dacryocystitis market is segmented based on treatment, application, and end-user. Based on treatment, the market is sub-segmented into oral antibiotics, systemic antibiotics, surgery, and others. On the basis of application, the market is sub-categorized into acute dacryocystitis, chronic dacryocystitis, congenital dacryocystitis, and others. Based on end-user, the market is further categorized into hospitals, ambulatory surgical centers, eye care centers, retail pharmacies, drug stores, and others.
Global Dacryocystitis Market Share by Treatment, 2020 (%)
Surgery Segment Projected to Secure Significant Share in Global Dacryocystitis Market
Based on treatments, surgery is an effective treatment procedure for severe dacryocystitis infection. Dacryocystitis usually can be treated with minimal conservative treatments. However, if the infection leads to blockage of the tear sacs (often the case with chronic dacryocystitis), then surgery is the best option to opt for. Dacryocystitis surgery is done to create a new opening or tear drain between the eyes and nose. This drain connects the lacrimal sac to the nasal cavity, which creates a new path for the tears to flow and helps to clear out the mucus and bacterial accumulation. With increasing dacryocystitis infection among children and the aged population, the number of dacryocystitis surgeries is also increasing, leading to segment growth.
Regional Outlook
Geographically, the global Dacryocystitis market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period. China and India are the major economies contributing to the market growth owing to the presence of a high population base, and rapid development in healthcare infrastructure. Moreover, the increasing number of eye infections among the population leads to the high demand for treatments.
Global Dacryocystitis Market Growth, By Region 2021-2027
North America Projected to Lead the Global Dacryocystitis Market
Geographically, North America dominated the market by accounting highest share in the Dacryocystitis market in 2020. The region is further projected to maintain its dominance during the forecast period. The US and Canada are the major economies driving the regional market growth. The rising Dacryocystitis patients in these economies is the major factor for the market growth. In addition, the government support in form of funding for R&D of pharmaceuticals drugs and investments by the pharmaceutical industry on R&D activities are further supporting the market growth. As per the Congressional Budget Office report, in 2019, the pharmaceutical industry spent $83 billion on R&D. The expenditures covered a variety of activities, including discovering and testing new drugs, developing incremental innovations such as product extensions, and clinical testing for safety monitoring. Such funding can lead to the introduction of new drugs to the market, which in turn, will boost the market growth.
Market Players Outlook
The key players in the dacryocystitis market contribute significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Abbott Laboratories, Aurobindo Pharma Ltd, Aurolab, Bess Medizintechnik GmbH, Cipla Ltd, FCI Ophthalmics, Kaneka Corp, Mylan Inc., Pfizer Inc., among others. These market players are adopting several market strategies including product launch and approvals, merger and acquisition, partnership collaboration, business, and capacity expansion, and others.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Dacryocystitis market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Dacryocystitis Industry
• Recovery Scenario of Global Dacryocystitis Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Trade Analysis
2.2.3. Porter’s Analysis
2.2.4. Recommendations
2.2.5. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Dacryocystitis Market, By Treatment
5.1.1. Oral antibiotics
5.1.2. Systemic antibiotics
5.1.3. Surgery
5.1.4. Others
5.2. Global Dacryocystitis Market, By Application
5.2.1. Acute Dacryocystitis
5.2.2. Chronic Dacryocystitis
5.2.3. Congenital Dacryocystitis
5.2.4. Others
5.3. Global Dacryocystitis Market, By End-User
5.3.1. Hospitals
5.3.2. Ambulatory surgical centers
5.3.3. Eye care centers
5.3.4. Retail pharmacies
5.3.5. Drug stores
5.3.6. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
6.4.1. Latin America
6.4.2. Middle East & Africa
7. Company Profiles
7.1.1. Abbott Laboratories
7.1.2. Aurobindo Pharma Ltd.
7.1.3. Aurolab
7.1.4. Bess Medizintechnik GmbH
7.1.5. Cipla Ltd
7.1.6. FCI Ophthalmics
7.1.7. Glaxosmithkline PLC
7.1.8. Gunther Weiss Scientific Glassblowing Co., Inc.
7.1.9. Kaneka Corp
7.1.10. Mylan Inc.
7.1.11. Nosch Labs Pvt. Ltd.
7.1.12. Orex Pharma Pvt Ltd,
7.1.13. Pfizer Inc.
1. GLOBAL DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
2. GLOBAL ORAL ANTIBIOTICS IN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
3. GLOBAL SYSTEMIC ANTIBIOTICS IN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL SURGERY IN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL OTHERS IN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
6. GLOBAL POWDER DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
7. GLOBAL DACRYOCYSTITIS FOR ACUTE DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL DACRYOCYSTITIS FOR CHRONIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL DACRYOCYSTITIS FOR CONGENITAL DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL DACRYOCYSTITIS FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
11. GLOBAL DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
12. GLOBAL DACRYOCYSTITIS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL DACRYOCYSTITIS IN AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL DACRYOCYSTITIS IN EYE CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL DACRYOCYSTITIS IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL DACRYOCYSTITIS IN DRUG STORES DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
17. GLOBAL DACRYOCYSTITIS IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
18. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
19. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
20. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
21. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
22. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
23. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
24. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
25. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
26. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
27. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
28. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
29. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
30. REST OF THE WORLD DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
31. REST OF THE WORLD DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
32. REST OF THE WORLD DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
33. REST OF THE WORLD DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL DACRYOCYSTITIS MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON GLOBAL DACRYOCYSTITIS MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF GLOBAL DACRYOCYSTITIS MARKET, 2020-2027 (%)
4. GLOBAL DACRYOCYSTITIS MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)
5. GLOBAL DACRYOCYSTITIS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
6. GLOBAL DACRYOCYSTITIS MARKET SHARE BY END-USER, 2020 VS 2027 (%)
7. GLOBAL DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
8. GLOBAL ORAL ANTIBIOTICS IN DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL SYSTEMIC ANTIBIOTICS IN DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
10. GLOBAL SURGERY IN DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
11. GLOBAL OTHERS IN DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
12. GLOBAL DACRYOCYSTITIS FOR ACUTE DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
13. GLOBAL DACRYOCYSTITIS FOR CHRONIC DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
14. GLOBAL DACRYOCYSTITIS FOR CONGENITAL DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
15. GLOBAL DACRYOCYSTITIS FOR OTHER APPLICATION MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
16. GLOBAL DACRYOCYSTITIS IN HOSPITALS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
17. GLOBAL DACRYOCYSTITIS IN AMBULATORY SURGICAL CENTERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
18. GLOBAL DACRYOCYSTITIS IN EYE CARE CENTERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
19. GLOBAL DACRYOCYSTITIS IN RETAIL PHARMACIES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
20. GLOBAL DACRYOCYSTITIS IN DRUG STORES DRUG STORES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
21. GLOBAL DACRYOCYSTITIS IN OTHER END-USERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
22. US DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
23. CANADA DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
24. UK DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
25. FRANCE DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
26. GERMANY DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
27. ITALY DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
28. SPAIN DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
29. REST OF EUROPE DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
30. INDIA DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
31. CHINA DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
32. JAPAN DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
33. REST OF ASIA-PACIFIC DACRYOCYSTITIS MARKET SIZE, 2020-2027 ($ MILLION)
34. REST OF THE WORLD DACRYOCYSTITIS MARKET SIZE, 2021-2027($ MILLION
